185490 — EyeGene Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for EyeGene, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	40,646	34,235	86,170	66,455	55,368
Net Total Accounts Receivable
Net Total Receivables	1,262	968	1,090	1,595	1,214
Total Inventory
Total Other Current Assets
Total Current Assets	43,150	36,117	88,644	68,830	56,877
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,308	3,549	5,864	5,742	9,851
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	47,309	44,427	104,991	80,381	78,103
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17,451	8,489	9,609	4,920	6,098
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	28,279	31,528	16,022	13,653	14,872
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	19,030	12,899	88,969	66,728	63,230
Total Liabilities & Shareholders' Equity	47,309	44,427	104,991	80,381	78,103
Total Common Shares Outstanding
Total Preferred Shares Outstanding